Fingerprint
Dive into the research topics of 'Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Thomas Urup, Signe Regner Michaelsen, Lars Rønn Olsen, Anders Toft, Ib Jarle Christensen, Kirsten Grunnet, Ole Winther, Helle Broholm, Michael Kosteljanetz, Shohreh Issazadeh-Navikas, Hans Skovgaard Poulsen, Ulrik Niels Lassen